Pulse Biosciences, Inc.PLSENASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P18
Within normal range
vs 5Y Ago
-2.9x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -19.47% |
| Q3 2025 | 7.26% |
| Q2 2025 | 5.90% |
| Q1 2025 | -19.46% |
| Q4 2024 | 61.27% |
| Q3 2024 | 32.38% |
| Q2 2024 | 25.76% |
| Q1 2024 | -24.48% |
| Q4 2023 | 25.24% |
| Q3 2023 | 7.08% |
| Q2 2023 | -5.44% |
| Q1 2023 | 11.43% |
| Q4 2022 | -34.42% |
| Q3 2022 | -31.68% |
| Q2 2022 | -25.52% |
| Q1 2022 | 7.31% |
| Q4 2021 | 22.13% |
| Q3 2021 | 4.26% |
| Q2 2021 | -22.35% |
| Q1 2021 | 49.46% |
| Q4 2020 | 6.64% |
| Q3 2020 | 8.26% |
| Q2 2020 | -4.94% |
| Q1 2020 | -19.58% |
| Q4 2019 | 27.97% |
| Q3 2019 | 8.94% |
| Q2 2019 | 16.93% |
| Q1 2019 | 15.39% |
| Q4 2018 | -32.79% |
| Q3 2018 | 9.70% |
| Q2 2018 | -3.90% |
| Q1 2018 | -7.21% |
| Q4 2017 | 39.48% |
| Q3 2017 | 10.26% |
| Q2 2017 | 209.18% |
| Q1 2017 | 40.23% |
| Q4 2016 | -2.58% |
| Q3 2016 | 39.10% |
| Q2 2016 | 21.59% |
| Q1 2016 | 26.55% |